BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34752602)

  • 1. Variance of Tumor Grade at Radical Prostatectomy With Assessment of Each Tumor Nodule Versus Global Grading.
    Iakymenko OA; Briski LM; Punnen S; Nemov I; Lugo I; Jorda M; Parekh DJ; Gonzalgo ML; Kryvenko ON
    Arch Pathol Lab Med; 2022 Aug; 146(8):1032-1036. PubMed ID: 34752602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
    Diolombi ML; Epstein JI
    BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
    Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
    Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy.
    Seyrek N; Hollemans E; Andrinopoulou ER; Osanto S; Pelger RCM; van der Poel HG; Bekers E; Remmers S; Schoots IG; van Leenders GJLH
    Virchows Arch; 2022 Jun; 480(6):1149-1157. PubMed ID: 35157140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical Prostatectomy.
    Hayee A; Lugo I; Iakymenko OA; Kwon D; Briski LM; Zhao W; Nemov I; Punnen S; Ritch CR; Pollack A; Jorda M; Stoyanova R; Parekh DJ; Gonzalgo ML; Kryvenko ON
    Arch Pathol Lab Med; 2022 Jul; 146(7):833-839. PubMed ID: 34669939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.
    Wissing M; Brimo F; Chevalier S; Scarlata E; McKercher G; O'Flaherty A; Aprikian S; Thibodeau V; Saad F; Carmel M; Lacombe L; Têtu B; Ekindi-Ndongo N; Latour M; Trudel D; Aprikian A
    BJU Int; 2019 Apr; 123(4):624-631. PubMed ID: 30113732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers.
    Kryvenko ON; Epstein JI; Merhe A; Iakymenko OA; E Silva RA; Chanamolu DK; Briski LM; Kwon D; Nemov I; Punnen S; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML
    Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38412318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.
    Iakymenko OA; Lugo I; Kwon D; Zhao W; Hayee A; Punnen S; Parekh DJ; Pollack A; Ritch CR; Gonzalgo ML; Stoyanova R; Jorda M; Kryvenko ON
    Urology; 2020 Mar; 137():108-114. PubMed ID: 31711982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion-targeted biopsies.
    Gordetsky JB; Schultz L; Porter KK; Nix JW; Thomas JV; Del Carmen Rodriguez Pena M; Rais-Bahrami S
    Hum Pathol; 2018 Jun; 76():68-75. PubMed ID: 29551676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomy.
    Preisser F; Wang N; Abrams-Pompe RS; Chun FK; Graefen M; Huland H; Tilki D
    Urol Oncol; 2022 Apr; 40(4):161.e9-161.e14. PubMed ID: 34973856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.
    Kryvenko ON; Iakymenko OA; De Lima Guido LP; Bhattu AS; Merhe A; Mouzannar A; Briski LM; Oymagil I; Lugo I; Nemov I; Ritch CR; Kava BR; Punnen S; Jorda M; Parekh DJ; Gonzalgo ML
    Arch Pathol Lab Med; 2022 Aug; 146(8):1012-1017. PubMed ID: 34739539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings.
    Steinberg DM; Sauvageot J; Piantadosi S; Epstein JI
    Am J Surg Pathol; 1997 May; 21(5):566-76. PubMed ID: 9158682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
    Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade migration and important prognostic factors in a pathology specimen for radical radiotherapy in prostate cancer patients.
    Majewski W; Lange D; Stanek-Widera A; Itrych B; Krzysztofiak T; Jarząb M; Oczko-Wojciechowska M; Kajor M; Tarnawski R
    Pol J Pathol; 2022; 73(1):27-33. PubMed ID: 35848478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.